Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $112.00 USD
Change Today +2.23 / 2.03%
Volume 9.2M
GILD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Xetra
As of 2:58 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Louis G. Lange M.D., Ph.D.

Senior Advisor, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 276 board members in 8 different organizations across 12 different industries.

See Board Relationships
65--

Background*

Dr. Louis G. Lange, also known as Lou, M.D., Ph.D. is a General Partner and Partner of Asset Management Ventures. Dr. Lange serves as an Advisor in the healthcare division at VantagePoint Capital Partners. He has been a Senior Advisor at Gilead Sciences Inc., since June 1, 2009. He founded Rapidscan Pharma Solutions, Inc. in 2010 and serves as its Chairman. He served as the Chairman, Chief Executive Officer and Chief Scientific Officer at CV Therapeutics, Inc. since ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

Trustee
Director
Director
Founder and Chairman
1992-N/A
Founder
2001-N/A
Former Director
2003-Present
Chairman and Chairman of Compensation Committee
2005-2013
Former Director, Chairman of Corporate Governance & Nominating Committee, Member of Compensation Committee and Member of Audit Committee
2008-Present
Director
2009-Present
Chairman of the Board
2010-2014
Former Director, Member of Compensation Committee and Member of Audit Committee
2014-Present
Director

Education*

PhD
Harvard University
Bachelor's Degree
University of Rochester
MD
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $112.04 USD +2.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.